发明公开
EP1606308A2 AN MHC-MOLEKÜLE BINDENDE TUMOR-ASSOZIIERTE PEPTIDE
审中-公开
MHC-MOLEKÜLEBINDENDE肿瘤 - ASSOZERERTE肽
- 专利标题： AN MHC-MOLEKÜLE BINDENDE TUMOR-ASSOZIIERTE PEPTIDE
- 专利标题（英）： Tumour-associated peptides binding to mhc molecules
- 专利标题（中）： MHC-MOLEKÜLEBINDENDE肿瘤 - ASSOZERERTE肽
-
申请号： EP04722556.0申请日： 2004-03-23
-
公开(公告)号： EP1606308A2公开(公告)日： 2005-12-21
- 发明人: RAMMENSEE, Hans, Georg , STEVANOVIC, Stefan , WEINSCHENK, Toni , LEMMEL, Claudia , DENGJEL, Jörn , SCHOOR, Oliver
- 申请人： Immatics Biotechnologies GmbH
- 申请人地址： Paul-Ehrlich-Str. 15 72076 Tübingen DE
- 专利权人： Immatics Biotechnologies GmbH
- 当前专利权人： Immatics Biotechnologies GmbH
- 当前专利权人地址： Paul-Ehrlich-Str. 15 72076 Tübingen DE
- 代理机构： Krauss, Jan
- 优先权： DE10313819 20030324
- 国际公布： WO2004085461 20041007
- 主分类号： C07K7/00
- IPC分类号： C07K7/00
摘要：
The invention relates to a tumour-associated peptide having an amino acid sequence selected from the group consisting of SEQ ID No. 1 to SEQ ID No. 101 from the associated sequence protocol, said peptide being able to bind to a molecule of the human major histocompatibility complex (MHC) class I. The invention also relates to the use of said peptides and the nucleic acids coding therefor, for producing a medicament and for the treatment of tumour diseases and/or adenomatous diseases. The invention further relates to a pharmaceutical composition comprising at least one of said peptides.
信息查询
